Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
29
ICLR Quote, Financials, Valuation and Earnings
Last price:
$126.44
Seasonality move
:
12.34%
Day range:
$126.40 - $132.34
52-week range:
$126.40 - $347.72
Dividend yield:
0%
P/E ratio:
13.79x
P/S ratio:
1.27x
P/B ratio:
1.06x
Volume:
1.5M
Avg. volume:
2M
1-year change:
-60.17%
Market cap:
$10.1B
Revenue:
$8.3B
EPS (TTM):
$9.18
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ICLR
Icon PLC
|
$2B | $3.09 | -6.81% | 83.13% | $181.94 |
|
APDN
Applied DNA Sciences
|
$1.2M | -$3.00 | 27.47% | -98.87% | -- |
|
FONR
Fonar
|
-- | -- | -- | -- | -- |
|
PRPH
ProPhase Labs
|
$2.5M | -$0.18 | 3.99% | -50% | $13.80 |
|
VCYT
Veracyte
|
$111M | $0.20 | 6.44% | 332.6% | $40.50 |
|
XWEL
XWELL
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ICLR
Icon PLC
|
$126.62 | $181.94 | $10.1B | 13.79x | $0.00 | 0% | 1.27x |
|
APDN
Applied DNA Sciences
|
$0.58 | -- | $640.5K | -- | $0.00 | 0% | 0.10x |
|
FONR
Fonar
|
$13.70 | -- | $86.3M | 10.96x | $0.00 | 0% | 0.85x |
|
PRPH
ProPhase Labs
|
$0.29 | $13.80 | $12M | -- | $0.00 | 0% | 1.56x |
|
VCYT
Veracyte
|
$27.61 | $40.50 | $2.2B | 67.34x | $0.00 | 0% | 4.71x |
|
XWEL
XWELL
|
$0.86 | -- | $4.5M | -- | $0.00 | 0% | 0.12x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ICLR
Icon PLC
|
26.47% | 0.899 | 24.6% | 1.21x |
|
APDN
Applied DNA Sciences
|
-- | 5.301 | -- | 3.97x |
|
FONR
Fonar
|
-- | 1.233 | -- | 9.69x |
|
PRPH
ProPhase Labs
|
22.08% | -4.436 | 25.3% | 0.84x |
|
VCYT
Veracyte
|
-- | 3.551 | -- | 4.54x |
|
XWEL
XWELL
|
-- | -0.848 | -- | 1.72x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ICLR
Icon PLC
|
$558.7M | $264.3M | 5.83% | 7.93% | 11.06% | $239.3M |
|
APDN
Applied DNA Sciences
|
$370.9K | -$3.5M | -84.02% | -84.02% | -352.03% | -$3.4M |
|
FONR
Fonar
|
$12.1M | $3.7M | 5.32% | 5.33% | 15.23% | $2.5M |
|
PRPH
ProPhase Labs
|
$526K | -$3.7M | -101.67% | -144.22% | -289.24% | -$3.4M |
|
VCYT
Veracyte
|
$79.5M | $1.2M | 2.85% | 2.85% | 1.02% | $3.5M |
|
XWEL
XWELL
|
$2.1M | -$4.6M | -71.82% | -71.82% | -54.82% | -$3.8M |
Icon PLC vs. Competitors
-
Which has Higher Returns ICLR or APDN?
Applied DNA Sciences has a net margin of 7.7% compared to Icon PLC's net margin of -336%. Icon PLC's return on equity of 7.93% beat Applied DNA Sciences's return on equity of -84.02%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B APDNApplied DNA Sciences37.71% -$15.35 $10.2M -
What do Analysts Say About ICLR or APDN?
Icon PLC has a consensus price target of $181.94, signalling upside risk potential of 43.69%. On the other hand Applied DNA Sciences has an analysts' consensus of -- which suggests that it could grow by 258386.99%. Given that Applied DNA Sciences has higher upside potential than Icon PLC, analysts believe Applied DNA Sciences is more attractive than Icon PLC.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 APDNApplied DNA Sciences0 1 0 -
Is ICLR or APDN More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison Applied DNA Sciences has a beta of 0.405, suggesting its less volatile than the S&P 500 by 59.491%.
-
Which is a Better Dividend Stock ICLR or APDN?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Applied DNA Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. Applied DNA Sciences pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or APDN?
Icon PLC quarterly revenues are $2B, which are larger than Applied DNA Sciences quarterly revenues of $983.4K. Icon PLC's net income of $154.2M is higher than Applied DNA Sciences's net income of -$3.3M. Notably, Icon PLC's price-to-earnings ratio is 13.79x while Applied DNA Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.27x versus 0.10x for Applied DNA Sciences. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.27x 13.79x $2B $154.2M APDNApplied DNA Sciences0.10x -- $983.4K -$3.3M
-
Which has Higher Returns ICLR or FONR?
Fonar has a net margin of 7.7% compared to Icon PLC's net margin of 9.23%. Icon PLC's return on equity of 7.93% beat Fonar's return on equity of 5.33%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B FONRFonar44.52% $0.37 $160.3M -
What do Analysts Say About ICLR or FONR?
Icon PLC has a consensus price target of $181.94, signalling upside risk potential of 43.69%. On the other hand Fonar has an analysts' consensus of -- which suggests that it could fall by --. Given that Icon PLC has higher upside potential than Fonar, analysts believe Icon PLC is more attractive than Fonar.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 FONRFonar0 0 0 -
Is ICLR or FONR More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison Fonar has a beta of 1.003, suggesting its more volatile than the S&P 500 by 0.30600000000001%.
-
Which is a Better Dividend Stock ICLR or FONR?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fonar offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. Fonar pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or FONR?
Icon PLC quarterly revenues are $2B, which are larger than Fonar quarterly revenues of $27.2M. Icon PLC's net income of $154.2M is higher than Fonar's net income of $2.5M. Notably, Icon PLC's price-to-earnings ratio is 13.79x while Fonar's PE ratio is 10.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.27x versus 0.85x for Fonar. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.27x 13.79x $2B $154.2M FONRFonar0.85x 10.96x $27.2M $2.5M
-
Which has Higher Returns ICLR or PRPH?
ProPhase Labs has a net margin of 7.7% compared to Icon PLC's net margin of -209.38%. Icon PLC's return on equity of 7.93% beat ProPhase Labs's return on equity of -144.22%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B PRPHProPhase Labs36.76% $0.11 $19.4M -
What do Analysts Say About ICLR or PRPH?
Icon PLC has a consensus price target of $181.94, signalling upside risk potential of 43.69%. On the other hand ProPhase Labs has an analysts' consensus of $13.80 which suggests that it could grow by 4708.36%. Given that ProPhase Labs has higher upside potential than Icon PLC, analysts believe ProPhase Labs is more attractive than Icon PLC.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 PRPHProPhase Labs0 0 0 -
Is ICLR or PRPH More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison ProPhase Labs has a beta of -0.472, suggesting its less volatile than the S&P 500 by 147.175%.
-
Which is a Better Dividend Stock ICLR or PRPH?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ProPhase Labs offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. ProPhase Labs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or PRPH?
Icon PLC quarterly revenues are $2B, which are larger than ProPhase Labs quarterly revenues of $1.4M. Icon PLC's net income of $154.2M is higher than ProPhase Labs's net income of $4M. Notably, Icon PLC's price-to-earnings ratio is 13.79x while ProPhase Labs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.27x versus 1.56x for ProPhase Labs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.27x 13.79x $2B $154.2M PRPHProPhase Labs1.56x -- $1.4M $4M
-
Which has Higher Returns ICLR or VCYT?
Veracyte has a net margin of 7.7% compared to Icon PLC's net margin of 6.16%. Icon PLC's return on equity of 7.93% beat Veracyte's return on equity of 2.85%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B VCYTVeracyte69.46% $0.09 $1.2B -
What do Analysts Say About ICLR or VCYT?
Icon PLC has a consensus price target of $181.94, signalling upside risk potential of 43.69%. On the other hand Veracyte has an analysts' consensus of $40.50 which suggests that it could grow by 46.69%. Given that Veracyte has higher upside potential than Icon PLC, analysts believe Veracyte is more attractive than Icon PLC.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 VCYTVeracyte7 2 1 -
Is ICLR or VCYT More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison Veracyte has a beta of 2.145, suggesting its more volatile than the S&P 500 by 114.466%.
-
Which is a Better Dividend Stock ICLR or VCYT?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veracyte offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. Veracyte pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or VCYT?
Icon PLC quarterly revenues are $2B, which are larger than Veracyte quarterly revenues of $114.5M. Icon PLC's net income of $154.2M is higher than Veracyte's net income of $7M. Notably, Icon PLC's price-to-earnings ratio is 13.79x while Veracyte's PE ratio is 67.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.27x versus 4.71x for Veracyte. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.27x 13.79x $2B $154.2M VCYTVeracyte4.71x 67.34x $114.5M $7M
-
Which has Higher Returns ICLR or XWEL?
XWELL has a net margin of 7.7% compared to Icon PLC's net margin of -56.4%. Icon PLC's return on equity of 7.93% beat XWELL's return on equity of -71.82%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B XWELXWELL24.38% -$0.99 $14.8M -
What do Analysts Say About ICLR or XWEL?
Icon PLC has a consensus price target of $181.94, signalling upside risk potential of 43.69%. On the other hand XWELL has an analysts' consensus of -- which suggests that it could grow by 712.07%. Given that XWELL has higher upside potential than Icon PLC, analysts believe XWELL is more attractive than Icon PLC.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 XWELXWELL0 0 0 -
Is ICLR or XWEL More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison XWELL has a beta of 1.014, suggesting its more volatile than the S&P 500 by 1.396%.
-
Which is a Better Dividend Stock ICLR or XWEL?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. XWELL offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. XWELL pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or XWEL?
Icon PLC quarterly revenues are $2B, which are larger than XWELL quarterly revenues of $8.4M. Icon PLC's net income of $154.2M is higher than XWELL's net income of -$4.8M. Notably, Icon PLC's price-to-earnings ratio is 13.79x while XWELL's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.27x versus 0.12x for XWELL. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.27x 13.79x $2B $154.2M XWELXWELL0.12x -- $8.4M -$4.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 45x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
WIX alert for May 22
Wix.com [WIX] is up 1.89% over the past day.
Buy
81
DY alert for May 22
Dycom Industries [DY] is down 1.02% over the past day.
Sell
50
FICO alert for May 22
Fair Isaac [FICO] is up 0.92% over the past day.
